Chris Lau

Chris Lau

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Did Altria Pay Too Much for Cronos Stock?

Altria stock wafted lower after announcing its investment in Cronos stock, and CRON is giving up gains too. What is going on?

7 Emerging Market Stocks to Buy on This Dip

In-flux trade tentions between the U.S. and China created a rare, time-sensitive buying opportunity for emerging market stocks.

Fitbit Stock Is Worth a Look

Fitbit stock could soon break out of its range to the upside. Fitbit's product refresh could drive sales, boosting FIT stock.

Pull-Back in Roku Stock Creates Welcome Entry Point for Investors

Roku's phenomenally strong third quarter is all but forgotten. If markets get another blowout quarter, ROKU stock will go up.

Why Is Apple Hiding Its iPhone Unit Sales Numbers?

Apple is not winning investor support by being more opaque with iPhone unit sales. That could hurt AAPL stock holders in the near-term.

The Red Hat Acquisition Could Do Wonders for IBM Stock

Markets are fretting over IBM's Red Hat acquisition, but this could be the magic bullet that sets IBM stock on a new growth path.

General Motors Stock Is a Bargain After Restructuring

General Motors is still a deep value play. The company's cost cuts will position GM stock toward high-growth automotive markets.

Investors May Be Underestimating Activision Stock

ATVI has fallen 40% from its 52-week highs, but ATVI stock has potential catalysts that could enable it to recover.

Pfizer Stock Has Multiple Positive Catalysts

Pfizer stock could be boosted by the company's rising investments and strong pipeline. PFE stock would be attractive on a major drop.

Buy Boring Cisco Systems as Market Uncertainties Grow

Cisco stock has many positive growth catalysts. Even a tariff war won't meaningfully hurt the outlook of CSCO stock..